An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

A new study led by researchers at Mass General Brigham suggests that different brain regions activated by creative tasks are part of one common brain circuit. By evaluating data from 857 participants ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

Tevogen Bio remains steadfast in its mission to pioneer accessible and affordable precision medicine while advocating for ...

Despite a constantly changing global position, Business Editor Alan Healy reports on Ireland's enduring appeal as a location ...

Patients with high-risk prostate cancer had a significantly lower incidence of distant metastasis when treated with a radiotherapy-based strategy compared with a radical prostatectomy-based approach, ...

And when researchers don't know what they’re allowed to do, science is not going to get done.” Science can be polarizing, ...

Dr. Varmus is a professor at Weill Cornell Medicine. He shared the 1989 Nobel Prize in medicine for the discovery of cancer ...

The process of separating useful molecules from mixtures of other substances accounts for 15% of the nation's energy, emits ...

A torrent of Trump administration policies is alarming scientists who fear the current climate is weakening researchers’ ...

Ketamine has received a Hollywood makeover. It used to be known as a rave drug (street name special K) and cat anesthetic. However, in recent years, some doctors have prescribed ketamine to treat ...

It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?